Cargando…

Prognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy

BACKGROUND: Deregulated signal transducer and activator of transcription 3 (STAT3) signaling has been well documented in certain cancers. Alterations in specific negative regulators, such as protein inhibitor of activated STAT3 (PIAS3), may contribute to cancer development. METHODS: The expression o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Sheau-Fang, Hou, Ming-Feng, Chen, Fang-Ming, Ou-Yang, Fu, Wu, Yang-Chang, Chai, Chee-Yin, Yeh, Yao-Tsung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714466/ https://www.ncbi.nlm.nih.gov/pubmed/26768588 http://dx.doi.org/10.1186/s12885-016-2063-1

Ejemplares similares

Crosstalk between Activated and Inactivated c-Src in Hepatocellular Carcinoma
por: Chen, Mei-Lin, et al.
Publicado: (2011)

Mitral Tissue Inhibitor of Metalloproteinase 2 Is Associated with Mitral Valve Surgery Outcome
por: Lin, Tsung-Hsien, et al.
Publicado: (2014)

The mitogen-activated protein kinase phosphatase-1 (MKP-1) gene is a potential methylation biomarker for malignancy of breast cancer
por: Chen, Fang-Ming, et al.
Publicado: (2012)

Prognostic value of Flotillin-1 expression in patients with solid tumors
por: Ou, Yang-xi, et al.
Publicado: (2017)

Prognostic value of inflammatory and nutritional indexes among advanced NSCLC patients receiving PD‐1 inhibitor therapy
por: Fang, Qiyu, et al.
Publicado: (2022)

Association between recurrent breast cancer and phthalate exposure modified by hormone receptors and body mass index
por: Yang, Pei-Jing, et al.
Publicado: (2022)

STAT gene family mRNA expression and prognostic value in hepatocellular carcinoma
por: Dong, Zhitao, et al.
Publicado: (2019)

Involvement of DNA Damage Response Pathways in Hepatocellular Carcinoma
por: Yang, Sheau-Fang, et al.
Publicado: (2014)

HDAC6 promotes aggressive development of liver cancer by improving egfr mRNA stability
por: Dai, Hong-Ying, et al.
Publicado: (2022)

Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
por: He, Yu-Xiang, et al.
Publicado: (2016)

Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression
por: Moi, Sin-Hua, et al.
Publicado: (2018)

miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis
por: Hsieh, Tsung-Hua, et al.
Publicado: (2014)

Independent Prognostic Value of Hypoxia-inducible Factor 1-alpha Expression in Small Cell Lung Cancer
por: Lin, Chang-Sheng, et al.
Publicado: (2017)

Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer
por: Hou, Ming-Feng, et al.
Publicado: (2021)

Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
por: Niu, Guo-Juan, et al.
Publicado: (2018)

Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors
por: Zhao, Xinmin, et al.
Publicado: (2022)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
por: Wang, Jing-Houng, et al.
Publicado: (2022)

Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer
por: Wang, Fang, et al.
Publicado: (2018)

Prognostic Value of EGFR Expression for Patients With Stage III Colorectal Cancer Receiving Fluoropyrimidine Metronomic Maintenance Therapy After Radical Resection and Adjuvant Oxaliplatin-Based Chemotherapy
por: Huang, Ching-Wen, et al.
Publicado: (2021)

Mechanism of Interleukin-4 Reducing Lipid Deposit by Regulating Hormone-Sensitive Lipase
por: Shiau, Ming-Yuh, et al.
Publicado: (2019)

Efficacy of Postoperative FOLFOX Versus XELOX Chemotherapy for Gastric Cancer and Prognostic Value of Platelet–Lymphocyte Ratio in Patients Receiving XELOX
por: Yin, Xin, et al.
Publicado: (2020)

Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors
por: Liu, Chunxun, et al.
Publicado: (2023)

The prognostic value of prognostic nutritional index in advanced cancer receiving PD‐1/L1 inhibitors: A meta‐analysis
por: Li, Pengfei, et al.
Publicado: (2022)

Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy
por: Lin, Chia-Hsin, et al.
Publicado: (2020)

Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study
por: Fang, Yu-Hung, et al.
Publicado: (2019)

Correlation between Cancer Stem Cells, Inflammation and Malignant Transformation in a DEN-Induced Model of Hepatic Carcinogenesis
por: Wu, Chun-Chieh, et al.
Publicado: (2022)

Prognostic Value of SDF-1α Expression in Patients with Esophageal Squamous Cell Carcinoma Receiving Esophagectomy
por: Chen, Yen-Hao, et al.
Publicado: (2020)

Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Prognostic value of fibrinogen-to-albumin ratio in patients with gastric cancer receiving first-line chemotherapy
por: Zhang, Liqun, et al.
Publicado: (2020)

Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis
por: Yang, Tao, et al.
Publicado: (2021)

Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy
por: Pang, Hui-Fang, et al.
Publicado: (2021)

The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
por: Huang, Ching-Wen, et al.
Publicado: (2013)

Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment
por: Gui, Ting, et al.
Publicado: (2015)

Secondary basal cell carcinoma of scalp after radiotherapy: A case report
por: Chen, Frank, et al.
Publicado: (2018)

The Prognostic Value of Deficient Mismatch Repair in Stage II–IVa Nasopharyngeal Carcinoma in the Era of IMRT
por: Chen, Fang-ming, et al.
Publicado: (2020)

Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine
por: Chen, Yi-Ting, et al.
Publicado: (2022)

Antioxidative Flavonol Glucuronides and Anti-HBsAg Flavonol from Rotala rotundifolia
por: Zhang, Li-Jie, et al.
Publicado: (2011)

The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy
por: Tsai, Tsung-Han, et al.
Publicado: (2023)

Potential Clinical Value of 5-Hydroxytryptamine Receptor 3C as a Prognostic Biomarker for Lung Cancer
por: Chen, Jiun-Rung, et al.
Publicado: (2021)

Patients with Earlobe Crease May Associate with Lower Concentration of the Age-Suppressing Hormone Klotho
por: Wang, Jian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g32h9ql8dbueg9oe5efcuret0g